211 related articles for article (PubMed ID: 25791814)
1. A novel topical nano-propranolol for treatment of infantile hemangiomas.
Chen ZG; Zheng JW; Yuan ML; Zhang L; Yuan WE
Nanomedicine; 2015 Jul; 11(5):1109-15. PubMed ID: 25791814
[TBL] [Abstract][Full Text] [Related]
2. Treatment of infantile hemangiomas with beta-blockers: a review.
Shah S; Frieden IJ
Skin Therapy Lett; 2013; 18(6):5-7. PubMed ID: 24305730
[TBL] [Abstract][Full Text] [Related]
3. Topical Timolol Maleate Treatment of Infantile Hemangiomas.
Püttgen K; Lucky A; Adams D; Pope E; McCuaig C; Powell J; Feigenbaum D; Savva Y; Baselga E; Holland K; Drolet B; Siegel D; Morel KD; Garzon MC; Mathes E; Lauren C; Nopper A; Horii K; Newell B; Song W; Frieden I;
Pediatrics; 2016 Sep; 138(3):. PubMed ID: 27527799
[TBL] [Abstract][Full Text] [Related]
4. Propranolol for treatment of ulcerated infantile hemangiomas.
Saint-Jean M; Léauté-Labrèze C; Mazereeuw-Hautier J; Bodak N; Hamel-Teillac D; Kupfer-Bessaguet I; Lacour JP; Naouri M; Vabres P; Hadj-Rabia S; Nguyen JM; Stalder JF; Barbarot S;
J Am Acad Dermatol; 2011 May; 64(5):827-32. PubMed ID: 21353332
[TBL] [Abstract][Full Text] [Related]
5. Topical propranolol for treatment of superficial infantile hemangiomas.
Xu G; Lv R; Zhao Z; Huo R
J Am Acad Dermatol; 2012 Dec; 67(6):1210-3. PubMed ID: 22516113
[TBL] [Abstract][Full Text] [Related]
6. Diagnosis and management of infantile hemangiomas.
Püttgen KB
Pediatr Clin North Am; 2014 Apr; 61(2):383-402. PubMed ID: 24636652
[TBL] [Abstract][Full Text] [Related]
7. Propranolol treatment for infantile hemangioma: a case series of sixty-two patients.
Stringari G; Barbato G; Zanzucchi M; Marchesi M; Cerasoli G; Tchana B; Gritti A; Boccaletti V; Lombardi AA; Carano N
Pediatr Med Chir; 2016 Jun; 38(2):113. PubMed ID: 27345601
[TBL] [Abstract][Full Text] [Related]
8. Propranolol for infantile hemangiomas.
Bagazgoitia L; Torrelo A; Gutiérrez JC; Hernández-Martín A; Luna P; Gutiérrez M; Baño A; Tamariz A; Larralde M; Alvarez R; Pardo N; Baselga E
Pediatr Dermatol; 2011; 28(2):108-14. PubMed ID: 21385205
[TBL] [Abstract][Full Text] [Related]
9. Late rebound of infantile hemangioma after cessation of oral propranolol.
Shehata N; Powell J; Dubois J; Hatami A; Rousseau E; Ondrejchak S; McCuaig C
Pediatr Dermatol; 2013; 30(5):587-91. PubMed ID: 24016283
[TBL] [Abstract][Full Text] [Related]
10. Assessment of the effectiveness of topical propranolol 4% gel for infantile hemangiomas.
Mashiah J; Kutz A; Rabia SH; Ilan EB; Goldberg I; Sprecher E; Harel A
Int J Dermatol; 2017 Feb; 56(2):148-153. PubMed ID: 28074521
[TBL] [Abstract][Full Text] [Related]
11. Oral propranolol: an effective, safe treatment for infantile hemangiomas.
Zaher H; Rasheed H; Hegazy RA; Hegazy RA; Abdelhalim DM; Gawdat HI
Eur J Dermatol; 2011; 21(4):558-63. PubMed ID: 21697036
[TBL] [Abstract][Full Text] [Related]
12. Effects of systemic propranolol treatment on physical growth of patients with infantile hemangiomas.
Hu L; Zhou B; Huang H; Chang L; Qiu Y; Ma G; Chen H; Jin Y; Xu X; Lin X; Li W
J Dermatol; 2016 Oct; 43(10):1160-1166. PubMed ID: 26945921
[TBL] [Abstract][Full Text] [Related]
13. Topical timolol as adjunct therapy to shorten oral propranolol therapy for infantile hemangiomas.
Mannschreck DB; Huang AH; Lie E; Psoter K; Puttgen K
Pediatr Dermatol; 2019 May; 36(3):283-289. PubMed ID: 30968438
[TBL] [Abstract][Full Text] [Related]
14. Propranolol and infantile hemangiomas: different routes of administration, a randomized clinical trial.
Zaher H; Rasheed H; Esmat S; Hegazy RA; Gawdat HI; Hegazy RA; El-Komy M; Abdelhalim DM
Eur J Dermatol; 2013; 23(5):646-52. PubMed ID: 24135427
[TBL] [Abstract][Full Text] [Related]
15. Topical propranolol therapy for infantile hemangiomas.
Kunzi-Rapp K
Pediatr Dermatol; 2012; 29(2):154-9. PubMed ID: 22141326
[TBL] [Abstract][Full Text] [Related]
16. Predictors of poor response to oral propranolol in infantile hemangiomas.
Hali F; Moubine I; Berrami H; Serhier Z; Othmani MB; Chiheb S
Arch Pediatr; 2023 Oct; 30(7):455-457. PubMed ID: 37394367
[TBL] [Abstract][Full Text] [Related]
17. Propranolol treatment for severe infantile hemangiomas: a single-centre 3-year experience.
Georgountzou A; Karavitakis E; Klimentopoulou A; Xaidara A; Kakourou T
Acta Paediatr; 2012 Oct; 101(10):e469-74. PubMed ID: 22804809
[TBL] [Abstract][Full Text] [Related]
18. Oral propranolol combined with topical timolol for compound infantile hemangiomas: a retrospective study.
Ge J; Zheng J; Zhang L; Yuan W; Zhao H
Sci Rep; 2016 Jan; 6():19765. PubMed ID: 26819072
[TBL] [Abstract][Full Text] [Related]
19. Propranolol, a very promising treatment for ulceration in infantile hemangiomas: a study of 20 cases with matched historical controls.
Hermans DJ; van Beynum IM; Schultze Kool LJ; van de Kerkhof PC; Wijnen MH; van der Vleuten CJ
J Am Acad Dermatol; 2011 May; 64(5):833-8. PubMed ID: 21353329
[TBL] [Abstract][Full Text] [Related]
20. [Response to oral propranolol therapy for ulcerated hemangiomas in infancy].
Michel JL; Patural H
Arch Pediatr; 2009 Dec; 16(12):1565-8. PubMed ID: 19892536
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
